Original Contribution
THE EFFECT OF COPPER SUPPLEMENTATION ON RED BLOOD CELL
OXIDIZABILITY AND PLASMA ANTIOXIDANTS IN MIDDLE-AGED
HEALTHY VOLUNTEERS
EDMOND ROCK,* ANDRZEJ MAZUR,* JACQUELINE M. O’CONNOR,
²
MAXINE P. BONHAM,
²
YVES RAYSSIGUIER,*
and JOHN J. STRAIN
²
*Unite ´ Maladies Me ´taboliques et Micronutriments, INRA-CRNH Saint Gene `s Champanelle, France
²
NICHE, University of Ulster, Coleraine, Northern Ireland
(Received 6 April 1999; Revised 4 November 1999; Accepted 4 November 1999)
Abstract—A multicenter European study (FoodCue) was undertaken to provide data on the significance of increased
dietary copper as a pro-oxidant or antioxidant in vivo. The present work describes the effect of Cu supplementation on
(2,2'-azo-bis(2-amidinopropane) hydrochloride (AAPH)-induced red blood cell oxidation in middle-aged people.
Double-blinded copper supplementation was achieved in 26 healthy volunteers (50 –70 years) with pills containing 3 mg
CuSO
4
, 3 mg Cu glycine chelate (CuG) and 6 mg CuG. Each 6 week supplementation period was preceded and followed
by 6 weeks of washout (WO) on placebo. The results show significant increases in time necessary to achieve 50%
hemolysis (LT
50
) after 3CuSO
4
and 6CuG compared with values after WO periods. Cu supplementation did not increase
the levels of (Cu,Zn)SOD activity in red blood cells. Resistance to hemolysis was significantly and positively correlated
(r = .30, p .01) with - and -carotene content in the plasma. Together, these data suggest that intake of copper as
high as 7 mg/d has no pro-oxidant activity and may rather result in protection of red blood cells against oxidation. The
decreased oxidizability of red blood cells did not result from increased (Cu,Zn)SOD activity and may occur through
other mechanisms such as changes in membrane antioxidant content. © 2000 Elsevier Science Inc.
Keywords—Copper supplementation, Human, Red blood cell oxidizability, Antioxidants, Carotene, Free radicals
INTRODUCTION
Copper (Cu) is an essential nutrient and is necessary to
maintain a number of physiological functions [1]. Al-
though overt Cu deficiency is not believed to be a sig-
nificant nutritional problem for populations, the current
recommendation of 1.5 to 3 mg Cu/d [2] is not com-
monly attained and may lead to suboptimal Cu status in
the population. When overt Cu deficiency occurs, symp-
toms include neutropenia, cardiac disorders, osteoporo-
sis, and anemia [3]. Anemia is classically observed dur-
ing severe Cu deficiency in laboratory animals. Many
studies, including those from our laboratory [4 – 6], have
established that red blood cells (RBC) from Cu-deficient
rats become more susceptible to in vitro–induced oxida-
tive stress. Such a pro-oxidant effect of Cu is attributed
to a decline of Cu-Zn SOD and extracellular SOD activ-
ities primarily involved in the removal of superoxide
anion, a highly toxic reactive oxygen species. This ac-
tivity was shown to be very sensitive to Cu intake,
particularly in animals and humans consuming low Cu-
containing diets [7].
On the other hand, Cu ions are well known to partic-
ipate in radical reactions such as the conversion of su-
peroxide to hydrogen peroxide and hydroxyl radicals.
Moreover, unstable Cu(III) form may be produced by
interaction of hydrogen peroxide or ascorbate with cu-
pric ion (CuII) [8]. It is assumed that such reactions are
involved, at least in part, during Cu-induced oxidation of
low-density lipoprotein (LDL) in vitro [9]. Pro-oxidant
activity of excess Cu intake has been shown in rats with
increased spin trap adduct in the bile, lipid peroxides in
the mitochondria, and 8-hydroxydeoxyguanosine in the
liver and kidney (reviewed in [10]). Antioxidant nutri-
ents (vitamin E, selenium) protect against Cu toxicity,
findings that are consistent with oxidative damage in-
Address correspondence to: Dr. Edmond Rock, Unite ´ Maladies Me ´
taboliques et Micronutriments, INRA-CRNH, 63 122 Saint Gene `s
Champanelle, France; Tel: +33 473- 62-41-69; Fax: +33 473-62-46-
38; E-Mail: rock@clermont.inra.fr.
Free Radical Biology & Medicine, Vol. 28, No. 3, pp. 324 –329,2000
Copyright © 2000 Elsevier Science Inc.
Printed in the USA. All rights reserved
0891-5849/00/$–see front matter
PII S0891-5849(99)00241-5
324